DENTSPLY SIRONA Inc. (XRAY)
NASDAQ: XRAY · Real-Time Price · USD
17.15
-1.67 (-8.85%)
Feb 27, 2025, 3:56 PM EST - Market closed
DENTSPLY SIRONA Revenue
In the year 2024, DENTSPLY SIRONA had annual revenue of $3.79B, down -4.34%. DENTSPLY SIRONA had revenue of $905.00M in the quarter ending December 31, 2024, a decrease of -10.57%.
Revenue (ttm)
$3.79B
Revenue Growth
-4.34%
P/S Ratio
1.01
Revenue / Employee
$252,867
Employees
15,000
Market Cap
3.41B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.79B | -172.00M | -4.34% |
Dec 31, 2023 | 3.97B | 43.00M | 1.10% |
Dec 31, 2022 | 3.92B | -309.00M | -7.30% |
Dec 31, 2021 | 4.23B | 892.00M | 26.71% |
Dec 31, 2020 | 3.34B | -683.00M | -16.98% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
XRAY News
- 1 hour ago - DENTSPLY SIRONA Inc. (XRAY) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 11 hours ago - Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook - GlobeNewsWire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Dentsply Sirona Inc. (XRAY) and Encourages Investors to Learn More About the Investigation - Accesswire
- 4 days ago - Dentsply Sirona Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Investors to Connect - Accesswire
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Reach Out - Accesswire
- 16 days ago - Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare - GlobeNewsWire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Dentsply Sirona Inc. (XRAY) And Encourages Stockholders to Connect - Accesswire